Top

Category: Vaccines


Industry, Vaccines

CHMP Approves Manufacturing Scale-Up for Spikevax

August 5, 2021

Via: Biopharm International

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has approved the increased manufacturing capacity and supply of Moderna’s COVID-19 vaccine (Spikevax) active substance in its United States manufacturing site. CHMP’s decision is expected to impact […]


Industry, Vaccines

Biden Offers COVID Vaccines to Migrants in Custody Along Mexican Border

August 4, 2021

Via: Drugs.com

COVID-19 vaccines will be offered to migrants in U.S. custody at the Mexican border, federal government officials said Tuesday. The Department of Homeland Security will provide the single-dose Johnson & Johnson vaccine to migrants soon after they cross into the […]


Industry, Vaccines

New Data Shows the Power of COVID Vaccines

August 2, 2021

Via: Drugs.com

The effectiveness of COVID-19 vaccines is borne out in new government data showing that more than 99.99% of fully vaccinated Americans have not had a breakthrough infection resulting in hospitalization or death. There were 6,587 COVID-19 breakthrough cases as of […]


Industry, Vaccines

U.S. sent Mexico and Canada AstraZeneca COVID-19 vaccines before fully vetting production site: report

July 29, 2021

Via: FiercePharma

Even on a day when there finally was good news about Emergent BioSolutions’ heavily scrutinized manufacturing facility in Baltimore—as it has been cleared to produce COVID-19 vaccines—there also was another dose of bad news involving the plant. According to a […]


Industry, Vaccines

BioNTech’s mRNA vaccine drive now includes malaria, TB shots

July 27, 2021

Via: Pharmaphorum

Human testing of the malaria shot should get underway by the end of 2022, according to the German biotech, which says it is working with the World Health Organization (WHO), European Commission and other organisations on the malaria project. There […]


Industry, Vaccines

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

July 26, 2021

Via: Medical News

The development and emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern that could potentially evade a vaccine-induced immune response is an ongoing concern, with the alpha (B.1.1.7), beta (B.1.351), gamma (B.1.248), and delta (B.1.614.2) lineages having […]


Industry, Vaccines

Biden Says Full Approval for COVID Vaccines Coming Soon

July 22, 2021

Via: Drugs.com

As he urged Americans who are still hesitant to get vaccinated, President Joe Biden told an Ohio town hall on Wednesday night that he expected the U.S. Food and Drug Administration would soon give final approval to COVID-19 vaccines. At […]


Industry, Vaccines

New advice issued on COVID-19 vaccination of children and young people

July 20, 2021

Via: Pharma Times

The new advice comes following a request from the Department of Health and Social Care (DHSC) for guidance relating to a possible extension of the COVID-19 vaccination programme in England. The JCVI, which advises UK health departments on immunisation, considered […]


Industry, Vaccines

AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues

July 15, 2021

Via: PMLiVE

J&J, AZ and the University of Oxford, alongside outside scientists, are planning to conduct early research into the potential of modifications to their vaccines to reduce or remove the risk of rare but serious blood clots associated with the jabs, […]


Industry, Vaccines

PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups

July 12, 2021

Via: Pharma Times

The study included one million people in at-risk groups, with those included in the study having underlying health conditions and more severe forms of illness. Conditions such as diabetes, severe asthma, chronic heart disease, chronic kidney disease, chronic liver disease, […]


Industry, Vaccines

What is behind the inconsistent results of COVID-19 clinical trials?

July 12, 2021

Via: Medical News

With the coronavirus disease 2019 (COVID-19) pandemic causing unprecedented morbidity and mortality, the development of an effective antiviral drug for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global health priority. Although many drug candidates have been identified […]


Industry, Vaccines

Valneva’s chikungunya virus vaccine granted breakthrough designation

July 9, 2021

Via: Pharma Times

The chikungunya vaccine – VLA1553 – has also previously been awarded an FDA fast track designation and a European Medicines Agency (EMA) PRIME designation, in December 2018 and October 2020 respectively. Chikungunya is a mosquito-borne viral disease caused by the […]